Cargando…

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine

BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible of the current pandemic ongoing all around the world. Since its discovery in 2019, several circulating variants have emerged and some of them are associated with increased infections and death rate. Des...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melo-González, Felipe, Soto, Jorge A., González, Liliana A., Fernández, Jorge, Duarte, Luisa F., Schultz, Bárbara M., Gálvez, Nicolás M. S., Pacheco, Gaspar A., Ríos, Mariana, Vázquez, Yaneisi, Rivera-Pérez, Daniela, Moreno-Tapia, Daniela, Iturriaga, Carolina, Vallejos, Omar P., Berríos-Rojas, Roslye V., Hoppe-Elsholz, Guillermo, Urzúa, Marcela, Bruneau, Nicole, Fasce, Rodrigo A., Mora, Judith, Grifoni, Alba, Sette, Alessandro, Weiskopf, Daniela, Zeng, Gang, Meng, Weining, González-Aramundiz, José V., González, Pablo A., Abarca, Katia, Ramírez, Eugenio, Kalergis, Alexis M., Bueno, Susan M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630786/ https://www.ncbi.nlm.nih.gov/pubmed/34858404 http://dx.doi.org/10.3389/fimmu.2021.747830

Ejemplares similares

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
por: Duarte, Luisa F., et al.
Publicado: (2021)

A Booster Dose of CoronaVac Increases Neutralizing Antibodies and T Cells that Recognize Delta and Omicron Variants of Concern
por: Schultz, Bárbara M., et al.
Publicado: (2022)

Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
por: Gálvez, Nicolás MS, et al.
Publicado: (2022)

Safety and immunogenicity evaluation of recombinant BCG vaccine against respiratory syncytial virus in a randomized, double-blind, placebo-controlled phase I clinical trial
por: Abarca, Katia, et al.
Publicado: (2020)

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
por: Méndez, Constanza, et al.
Publicado: (2023)

The Role of Dendritic Cells During Infections Caused by Highly Prevalent Viruses
por: Soto, Jorge A., et al.
Publicado: (2020)

Inactivated Vaccine-Induced SARS-CoV-2 Variant-Specific Immunity in Children
por: Soto, Jorge A., et al.
Publicado: (2022)

Characterization of the humoral and cellular immunity induced by a recombinant BCG vaccine for the respiratory syncytial virus in healthy adults
por: Pacheco, Gaspar A., et al.
Publicado: (2023)

Differential Severe Acute Respiratory Syndrome Coronavirus 2–Specific Humoral Response in Inactivated Virus–Vaccinated, Convalescent, and Breakthrough-Infected Subjects
por: Duarte, Luisa F, et al.
Publicado: (2023)

Molecular and Cellular Mechanisms Modulating Trained Immunity by Various Cell Types in Response to Pathogen Encounter
por: Acevedo, Orlando A., et al.
Publicado: (2021)

Induction of Trained Immunity by Recombinant Vaccines
por: Covián, Camila, et al.
Publicado: (2021)

Human T Cell Response to Dengue Virus Infection
por: Tian, Yuan, et al.
Publicado: (2019)

Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial
por: Abarca, Katia, et al.
Publicado: (2022)

Horizontally Acquired Homologs of Xenogeneic Silencers: Modulators of Gene Expression Encoded by Plasmids, Phages and Genomic Islands
por: Piña-Iturbe, Alejandro, et al.
Publicado: (2020)

SARS-CoV-2: Immune Response Elicited by Infection and Development of Vaccines and Treatments
por: Canedo-Marroquín, Gisela, et al.
Publicado: (2020)

Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species
por: Xu, Xiaojun, et al.
Publicado: (2016)

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
por: Grifoni, Alba, et al.
Publicado: (2021)

SARS-CoV-2 human T cell epitopes: Adaptive immune response against COVID-19
por: Grifoni, Alba, et al.
Publicado: (2022)

Bacterial and Viral Coinfections with the Human Respiratory Syncytial Virus
por: Pacheco, Gaspar A., et al.
Publicado: (2021)

Antibody development for preventing the human respiratory syncytial virus pathology
por: Soto, Jorge A., et al.
Publicado: (2020)

The Importance of Nanocarrier Design and Composition for an Efficient Nanoparticle-Mediated Transdermal Vaccination
por: Valdivia-Olivares, Rayen Yanara, et al.
Publicado: (2021)

T-Cell Immunity to Infection with Dengue Virus in Humans
por: Weiskopf, Daniela, et al.
Publicado: (2014)

Bioinformatic and experimental characterization of SEN1998: a conserved gene carried by the Enterobacteriaceae-associated ROD21-like family of genomic islands
por: Piña-Iturbe, Alejandro, et al.
Publicado: (2022)

Non-capsular based immunization approaches to prevent Streptococcus pneumoniae infection
por: Silva, Pedro H., et al.
Publicado: (2022)

Identification of Novel Yellow Fever Class II Epitopes in YF-17D Vaccinees
por: Mateus, Jose, et al.
Publicado: (2020)

Conserved epitopes with high HLA-I population coverage are targets of CD8(+) T cells associated with high IFN-γ responses against all dengue virus serotypes
por: Adikari, Thiruni N., et al.
Publicado: (2020)

Single Nucleotide Polymorphisms in Apolipoprotein B, Apolipoprotein E, and Methylenetetrahydrofolate Reductase Are Associated With Serum Lipid Levels in Northern Chilean Subjects. A Pilot Study
por: Gálvez, Anita S., et al.
Publicado: (2021)

Innate Immune Components That Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections
por: Andrade, Catalina A., et al.
Publicado: (2020)

Development of a novel clustering tool for linear peptide sequences
por: Dhanda, Sandeep K., et al.
Publicado: (2018)

New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV
por: Gálvez, Nicolás M. S., et al.
Publicado: (2017)

Different Safety Pattern of an Inactivated SARS-CoV-2 Vaccine (CoronaVac(®)) According to Age Group in a Pediatric Population from 3 to 17 Years Old, in an Open-Label Study in Chile
por: Le Corre, Nicole, et al.
Publicado: (2023)

Cytokines in the Respiratory Airway as Biomarkers of Severity and Prognosis for Respiratory Syncytial Virus Infection: An Update
por: Vázquez, Yaneisi, et al.
Publicado: (2019)

Induction of Protective Immunity by a Single Low Dose of a Master Cell Bank cGMP-rBCG-P Vaccine Against the Human Metapneumovirus in Mice
por: Soto, Jorge A., et al.
Publicado: (2021)

Cytotoxic CD4 T Cells: Differentiation, Function, and Application to Dengue Virus Infection
por: Tian, Yuan, et al.
Publicado: (2016)

Modulation of Immune Cells as a Therapy for Cutaneous Lupus Erythematosus
por: Soto, Jorge A., et al.
Publicado: (2022)

BCG-Based Vaccines Elicit Antigen-Specific Adaptive and Trained Immunity against SARS-CoV-2 and Andes orthohantavirus
por: Soto, Jorge A., et al.
Publicado: (2022)

Contribution of hypoxia inducible factor-1 during viral infections
por: Reyes, Antonia, et al.
Publicado: (2020)

Limited Heme Oxygenase Contribution to Modulating the Severity of Salmonella enterica serovar Typhimurium Infection
por: Sebastián, Valentina P., et al.
Publicado: (2022)

Human Metapneumovirus: Mechanisms and Molecular Targets Used by the Virus to Avoid the Immune System
por: Soto, Jorge A., et al.
Publicado: (2018)

Characterization of the Anti-Inflammatory Capacity of IL-10-Producing Neutrophils in Response to Streptococcus pneumoniae Infection
por: González, Liliana A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o20p5k87vgvd1q4clvg1hee4n3